Arizona Metals Corp. Stock Price, News, Quote & History

Arizona Metals Corp is a mineral exploration company. It is engaged in gold and copper deposits. The firm's projects are the Kay mine project and the Sugarloaf peak gold project.

Arizona Metals Corp.

Arizona Metals Announces Appointment of Pamela Saxton to Board of Directors; Extends Kay Deposit to 1,350 m Depth and Confirms Continuity of Kay Mineralized Horizon 280 m North of Previous Drilling

Arizona Metals Files Technical Report for the Kay Mine Project

Arizona Metals Corp Announces Annual General Meeting and Deferral of Shareholder Vote on Previously Proposed Spin-Out Transactions

Arizona Metals Announces Management Transition; Welcomes Duncan Middlemiss as President and CEO and Jacques Perron as Chair of the Board

Arizona Metals Corp Acquires Additional Private Land for Development Infrastructure

Arizona Metals Intersects 20.1 m at 3.4% CuEq and 38.0 m at 1.4% CuEq in Kay Mine Expansion Drilling

5 Best-performing Canadian Uranium Stocks of 2025

Tech Weekly: Market Dives After Week-Long Rally as US-China Tensions Reignite

Investing in Gold Royalty and Streaming Stocks

Inside Billionaire Gina Rinehart's Key Mining Investments

Hudbay Secures US$600 Million Mitsubishi Partnership for Arizona Copper Project

Top 9 Global Lithium Stocks of 2025

5 Top Weekly TSX Performers: Index Rises Above 20,000

Arizona's Gold Rush: A Modern-day Opportunity for Investors

Latest News

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran in Patients with Hereditary Angioedema

Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

Latest News

Outlook Reports world

Featured Copper Investing Stocks

Empire Metals

Canada One Mining

African Discovery Group

Copper Quest Exploration

Corazon Mining

Blackstone Minerals

Browse Companies